John Hanson

11.7k total citations · 1 hit paper
131 papers, 9.0k citations indexed

About

John Hanson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John Hanson has authored 131 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 32 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John Hanson's work include Palliative Care and End-of-Life Issues (28 papers), Pain Management and Opioid Use (23 papers) and Cancer survivorship and care (18 papers). John Hanson is often cited by papers focused on Palliative Care and End-of-Life Issues (28 papers), Pain Management and Opioid Use (23 papers) and Cancer survivorship and care (18 papers). John Hanson collaborates with scholars based in Canada, United States and India. John Hanson's co-authors include Éduardo Bruera, Tara MacEachern, Robin L. Fainsinger, Catherine M. Neumann, María E. Suarez‐Almazor, Peter G. Lawlor, Karen Macmillan, Bruno Gagnon, John R. Mackey and R. Neil MacDonald and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

John Hanson

129 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Occurrence, Causes, and Outcome of Delirium in Patients With Advanced Cancer

2000 561 citations Peter G. Lawlor, Bruno Gagnon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Hanson Canada	52	2.8k	2.5k	2.1k	2.0k	1.9k	131	9.0k
Nathan I. Cherny Israel	46	2.0k 0.7×	3.9k 1.6×	3.3k 1.5×	3.2k 1.6×	861 0.4×	152	9.1k
Cinzia Brunelli Italy	40	1.6k 0.6×	1.8k 0.7×	1.3k 0.6×	1.5k 0.7×	547 0.3×	164	5.4k
Eva Skovlund Norway	47	3.9k 1.4×	577 0.2×	407 0.2×	679 0.3×	1.9k 1.0×	253	9.0k
Gary B. Chisholm United States	38	1.8k 0.6×	2.3k 0.9×	386 0.2×	1.3k 0.7×	555 0.3×	123	6.0k
Marco Maltoni Italy	30	1.7k 0.6×	2.4k 0.9×	1.1k 0.5×	1.4k 0.7×	386 0.2×	123	4.7k
A. G. H. Kessels Netherlands	27	1.2k 0.4×	654 0.3×	1.4k 0.7×	949 0.5×	728 0.4×	58	5.3k
S. Kaasa Norway	49	4.0k 1.4×	1.9k 0.8×	965 0.5×	2.4k 1.2×	2.0k 1.0×	116	8.3k
Victor T. Chang United States	37	2.2k 0.8×	1.6k 0.6×	829 0.4×	1.6k 0.8×	814 0.4×	143	5.1k
Michael P. W. Grocott United Kingdom	61	1.2k 0.4×	555 0.2×	453 0.2×	431 0.2×	2.6k 1.3×	329	11.5k
Edward J. Mascha United States	54	323 0.1×	905 0.4×	1.1k 0.5×	801 0.4×	2.5k 1.3×	200	10.1k

Countries citing papers authored by John Hanson

Since Specialization

Citations

This map shows the geographic impact of John Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hanson more than expected).

Fields of papers citing papers by John Hanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hanson. The network helps show where John Hanson may publish in the future.

Co-authorship network of co-authors of John Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of John Hanson. A scholar is included among the top collaborators of John Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hanson. John Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hugh, Judith, Gilbert Bigras, Xiuying Hu, et al.. (2021). DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial. Heliyon. 8(1). e08666–e08666. 2 indexed citations

Sawyer, Michael B., Edith Pituskin, Sambasivarao Damaraju, et al.. (2015). A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. Clinical Breast Cancer. 16(2). 139–144.e3. 17 indexed citations

Jung, Karen, Siham Sabri, John Hanson, et al.. (2015). ElevatedARG1expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patients. Cancer Biology & Therapy. 16(9). 1281–1288. 10 indexed citations

Abdulkarim, Bassam, Julie Cuartero, John Hanson, et al.. (2011). Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy. Journal of Clinical Oncology. 29(21). 2852–2858. 247 indexed citations

Gabos, Zsolt, John Thoms, Sunita Ghosh, et al.. (2010). The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Research and Treatment. 124(1). 187–194. 65 indexed citations

Hugh, Judith, John Hanson, Maggie C.U. Cheang, et al.. (2009). Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial. Journal of Clinical Oncology. 27(8). 1168–1176. 407 indexed citations

Fainsinger, Robin L., Alysa Fairchild, Cheryl Nekolaichuk, et al.. (2008). Is Pain Intensity a Predictor of the Complexity of Cancer Pain Management?. Journal of Clinical Oncology. 27(4). 585–590. 81 indexed citations

McNeely, Margaret L., Matthew Parliament, Kerry S. Courneya, et al.. (2004). A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head & Neck. 26(6). 518–530. 106 indexed citations

Olson, Karin, John Hanson, Dawn Stacey, et al.. (2004). Évaluation de la fidélité et de la validité du système révisé de classification de la stomatite du WCCNR lorsqu’elle résulte d’un traitement anticancéreux. Canadian Oncology Nursing Journal. 14(3). 176–182. 1 indexed citations

10.

Lawlor, Peter G., Bruno Gagnon, Isabelle Mancini, et al.. (2001). Clinical and Ethical Questions Concerning Delirium Study on Patients With Advanced Cancer—Reply. JAMA Internal Medicine. 161(2). 297–297. 1 indexed citations

11.

Bruera, Éduardo, et al.. (2000). The Frequency and Correlates of Dyspnea in Patients with Advanced Cancer. Journal of Pain and Symptom Management. 19(5). 357–362. 162 indexed citations

12.

Barnes, Elizabeth, John Hanson, Catherine M. Neumann, Cheryl Nekolaichuk, & Éduardo Bruera. (2000). Communication Between Primary Care Physicians and Radiation Oncologists Regarding Patients With Cancer Treated With Palliative Radiotherapy. Journal of Clinical Oncology. 18(15). 2902–2907. 40 indexed citations

13.

Gagnon, Bruno, et al.. (1999). The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Supportive Care in Cancer. 7(4). 265–270. 31 indexed citations

14.

Bruera, Éduardo, et al.. (1999). Edmonton Regional Palliative Care Program: impact on patterns of terminal cancer care.. PubMed. 161(3). 290–3. 69 indexed citations

15.

Conno, Franco De, Carla Ripamonti, L. Saita, et al.. (1995). Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain.. Journal of Clinical Oncology. 13(4). 1004–1008. 48 indexed citations

16.

Bruera, Éduardo, et al.. (1991). The Edmonton injector: A simple device for patient-controlled subcutaneous analgesia. Pain. 44(2). 167–169. 23 indexed citations

17.

Dietrich, Kevin, J Danyluk, Anne Paterson, et al.. (1991). Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.. PubMed. 51(2). 556–67. 228 indexed citations

18.

Bruera, Éduardo, Ken MacMillan, John Hanson, & R. Neil MacDonald. (1989). The Edmonton staging system for cancer pain: preliminary report. Pain. 37(2). 203–209. 196 indexed citations

19.

Bruera, Éduardo, Carleen Brenneis, Mary Michaud, et al.. (1988). Patient-Controlled Subcutaneous Hydromorphone Verus Continuous Subcutaneous Infusion for the Treatment Cancer Pain. JNCI Journal of the National Cancer Institute. 80(14). 1152–1154. 37 indexed citations

20.

Bain, Gordon O., Maria Koch, & John Hanson. (1982). Feasibility of Grading Prostatic Carcinomas. The Journal of Urology. 128(6). 1417–1418. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact